Home Updates ACT-AD Urges House and Senate Appropriations Subcommittee Leadership to Increase Funds for FDA Drug Review Activities
Update

ACT-AD Urges House and Senate Appropriations Subcommittee Leadership to Increase Funds for FDA Drug Review Activities

  March 31, 2008 at 5:38 pm

ACT-AD urged House and Senate Appropriations Subcommittee leadership to increase funds for FDA drug review activities in FY 2009.
Read Letter

File Attachments
  actadletter (1M PDF)
Categories:
Uncategorized
  Recent Updates
FDA Grants Accelerated Approval for Alzheimer’s Drug
June 7, 2021
Study: Impact of International Reference Pricing on Alzheimer’s Research and Development
April 22, 2021
Sponsor Spotlight: Avanir’s Sanjay Dubé, M.D.
March 3, 2021
13th Annual FDA/ACT-AD Allies Meeting Recap
February 17, 2021
  Newsletter Signup